ARCA biopharma
Westminster
About ARCA biopharma
ARCA biopharma, Inc. is a Colorado-based biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases. ARCA’s principal focus is to develop personalized therapies for the treatment of cardiovascular disease through the use of genetics. The Company’s business focus combines expertise in cardiovascular pathophysiology, molecular genetics and clinical development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $90.4M
- Funding stage: M&A
- Last round: Post-IPO Equity (Jun 2015)
- Ticker: nasdaq:ABIO
- Website: arcabiopharma.com
- Phone: +7209402200
Industries & Categories
Biotechnology, Genetics, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/arca-biopharma-3573086 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.